Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Tickers
CALT
MCK
NVS
RHHBY
Tags
Health Care Distributors
Briefs
Expert Ideas
From
Benzinga
Fusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside
December 20, 2023
Tickers
AZN
FUSN
NVS
Tags
Briefs
Expert Ideas
Biotech
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 20, 2023
Tickers
NVS
Tags
Short Ideas
Benzinga
Trading Ideas
From
Benzinga
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
December 19, 2023
Tickers
LNTH
NVS
PNT
Tags
Markets
Downgrades
Analyst Color
From
Benzinga
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
December 17, 2023
Tickers
ECX
FSR
FTRE
GELYF
Tags
TSM
LLY
PSNY
From
InvestorPlace
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Tickers
MRK
NVS
Tags
Briefs
Large Cap
News
From
Benzinga
Novartis' Newly FDA-Approved Rare Blood Disorder Drug Aces Phase 3 Study In Ultra Rare Kidney Failure Disease
December 11, 2023
Tickers
NVS
Tags
General
Markets
Eurasia
From
Benzinga
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
December 10, 2023
Tickers
BMY
GILD
NVS
Tags
BMY
GILD
NVS
From
Motley Fool
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Tickers
NVS
Tags
NVS
Market News
FDA
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 01, 2023
Tickers
NVS
Tags
NVS
Market News
BZI/SHORTHIST
From
Benzinga
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
Tickers
BMY
GILD
JNJ
NVS
Tags
Market News
NVS
GILD
From
Benzinga
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
November 28, 2023
Tickers
BMY
CABA
GILD
GRCL
Tags
CABA
GRCL
NVS
From
MarketWatch
3 Healthcare Stocks to Pick Up Before the Year-End Rally
November 28, 2023
Tickers
BSX
NVS
UNH
Tags
Stocks to Buy
BSX
UNH
From
InvestorPlace
Novartis Outlines Pure-Play Strategy Progress After Generics Business Spin-Off
November 28, 2023
Tickers
NVS
Tags
General
NVS
Market News
From
Benzinga
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
November 16, 2023
Tickers
CVRX
JNJ
LEGN
NVS
Tags
JNJ
Recent Press Releases
CVRX
From
Motley Fool
Verve Therapeutics’ stock falls 40% as analysts question safety of cholesterol-cutting gene-editing treatment
November 13, 2023
Tickers
BEAM
LLY
NVS
SPX
Tags
VERV
BEAM
NVS
From
MarketWatch
How Is The Market Feeling About Novartis?
November 10, 2023
Tickers
NVS
Tags
Short Sellers
BZI/SHORTHIST
Market News
From
Benzinga
3 Spectacular High-Yield Dividend Stocks to Buy in November
November 05, 2023
Tickers
ABBV
NVS
PFE
Tags
NVS
Recent Press Releases
Market News
From
Motley Fool
Novartis' Rare Kidney Disease Candidate Aces Late-Stage Study
October 30, 2023
Tickers
NVS
Tags
Benzinga
Health Care
Biotech
From
Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
Tickers
AAPL
ADM
AGYS
AJG
Tags
HAS
PFE
SBUX
From
Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
Tickers
BHC
CAH
CVS
NVS
Tags
RHHBY
CAH
Markets
From
Benzinga
3 No-Brainer Stocks to Buy for Under $100 Right Now
October 28, 2023
Tickers
AZN
BNTX
NVS
Tags
AZN
Recent Press Releases
NVS
From
Motley Fool
2 Green Flags and 1 Red Flag for Novartis Stock
October 27, 2023
Tickers
NVS
Tags
Recent Press Releases
NVS
Market News
From
Motley Fool
7 Undervalued Stocks to Buy Before Everyone Else
October 26, 2023
Tickers
AAL
CLFD
DAL
DB
Tags
TTWO
RTX
CLFD
From
InvestorPlace
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript
October 24, 2023
Tickers
NVS
Tags
NVS
Recent Press Releases
Market News
From
Motley Fool
US Stock Futures Surge Ahead Of Microsoft, Google Earnings: Analyst Says 'Magnificent Seven' Unlikely To See Tesla-Like Volatility After Results
October 24, 2023
Tickers
ADM
BYD
COIN
DOW
Tags
Economics
Louis Navellier
News
From
Benzinga
Novartis Q3: Earnings Beat, Raised Operating Profit Outlook & More
October 24, 2023
Tickers
NVS
SDZNY
Tags
Equities
Guidance
Large Cap
From
Benzinga
Earnings Outlook For Novartis
October 23, 2023
Tickers
NVS
Tags
BZI/EP
Earnings
Benzinga
From
Benzinga
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
October 23, 2023
Tickers
AA
ADM
AGYS
AJG
Tags
GM
AGYS
ADM
From
Benzinga
7 Healthcare Stocks to invest in for a Healthy Future
October 20, 2023
Tickers
GILD
HLN
MDT
MRK
Tags
MRK
HLN
WST
From
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.